B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Rigosertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Rigosertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

tepotinib
2 shared targets
jnj
2 shared targets
tucatinib
2 shared targets
sgx
2 shared targets
mk
3 shared targets
osi
2 shared targets
bdb
2 shared targets
bdb
2 shared targets
linsitinib
2 shared targets
lenvatinib
2 shared targets
Loading evidence profile...

This evidence profile for Rigosertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.